Skip to main content
ChemPartner PharmaTech Co., Ltd. logo

ChemPartner PharmaTech Co., Ltd. — Investor Relations & Filings

Ticker · 300149 ISIN · CNE100000Y27 Shenzhen Stock Exchange Professional, scientific and technical activities
Filings indexed 2,256 across all filing types
Latest filing 2018-05-14 Major Shareholding Noti…
Country CN China
Listing Shenzhen Stock Exchange 300149

About ChemPartner PharmaTech Co., Ltd.

https://www.chempartner.com

ChemPartner PharmaTech Co., Ltd. is a global research and development organization providing comprehensive drug discovery and development services. Operating as a Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), the company supports pharmaceutical and biotechnology clients through an integrated service platform. Core capabilities include medicinal chemistry, biology, pharmacology, drug metabolism and pharmacokinetics (DMPK), and toxicology. The organization also offers specialized expertise in biologics discovery, protein engineering, and antibody development. ChemPartner facilitates the transition from early-stage research to clinical development through its pharmaceutical development and manufacturing capabilities, utilizing advanced technology to accelerate the discovery and production of novel therapeutic agents.

Recent filings

Filing Released Lang Actions
关于实际控制人部分股份解除质押的公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the release of pledged shares by a major shareholder and actual controller of the company. It details the number of shares released from pledge, dates, and percentages of shareholding affected. There is no financial report, earnings data, or management discussion. The content fits the category of a Major Shareholding Notification, as it concerns changes in significant share ownership levels and pledging status. The document length is short and focused on shareholding changes, not a full report or announcement of a report publication.
2018-05-14 Chinese
关于公司股东减持计划时间过半未减持公司股份的进展公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the progress of a shareholder's plan to reduce their holdings in the company. It details that the shareholder has not yet reduced shares as planned and provides regulatory references to stock exchange rules about share reduction. There is no financial data, earnings information, or report attached. The content fits the category of a Major Shareholding Notification, as it concerns changes (or lack thereof) in significant share ownership levels and compliance with disclosure rules.
2018-05-09 Chinese
关于控股股东开展融资融券业务的公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement regarding the controlling shareholder's engagement in margin financing and securities lending business, specifically the transfer of shares into a securities account for credit trading purposes. It provides details on shareholding percentages and confirms no change in ownership. The document length is only 594 characters, indicating it is a brief regulatory announcement rather than a full financial report. It does not contain financial statements, management discussion, or detailed financial data. This fits the category of Capital/Financing Update (CAP), as it relates to financing activities involving the company's shares by a major shareholder.
2018-05-09 Chinese
独立董事关于第三届董事会第四十三次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from the independent directors of Quantum Hi-Tech (China) Biological Co., Ltd. regarding a specific board meeting (the 43rd meeting of the third board). It discusses the cancellation of certain granted stock options due to employees leaving and conditions not being met. The document references compliance with stock exchange listing rules and company articles but does not contain financial statements or detailed financial data. It is a formal opinion related to board matters, specifically about stock option cancellations, which is a management/board-related announcement rather than a full report or financial statement. The document length is short (863 characters), and it is not a report publication announcement or certification. Therefore, the best fitting category is Board/Management Information (MANG), as it relates to board decisions and management matters.
2018-04-26 Chinese
第三届监事会第三十一次会议决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Quantum Hi-Tech (China) Biological Co., Ltd. It reports on the approval of the company's 2018 first quarter report and the cancellation of some stock options. The document is a formal announcement of meeting resolutions and does not contain the full quarterly report or detailed financial data itself. It also includes voting results for the resolutions passed. Given the nature of the content—meeting resolutions and voting outcomes related to company governance and stock options—the document fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short and it is not the report itself but an announcement of decisions made regarding the report and stock options.
2018-04-26 Chinese
2018年第一季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled "量子高科(中国)生物股份有限公司 2018 年第一季度报告全文" which translates to "Quantum Hi-Tech (China) Biological Co., Ltd. 2018 First Quarter Report Full Text." It contains detailed financial data for the first quarter of 2018, including income statement, balance sheet, cash flow statement, risk factors, shareholder information, and business outlook. The presence of quarterly financial data, management discussion of business risks, and operational details indicates this is a comprehensive interim financial report for a period shorter than a full fiscal year. The document is about 15,000 characters long, which is consistent with a full quarterly report rather than a brief announcement or summary. Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2018-04-26 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.